Psoriasis exacerbation after COVID-19 vaccination in high-risk group: How to manage it?

Kabbani, Mariam; Poskin, Maud; Benhadou, Farida

Kabbani, Mariam; Poskin, Maud; Benhadou, Farida.

Kabbani M; Dermatology Department, Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Poskin M; General Practice, Maison Médicale Marconi, Brussels, Belgium.
Benhadou F; Dermatology Department, Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Dermatol Ther ; 35(5): e15368, 2022 05.

Article in English | MEDLINE | ID: covidwho-1673053

Subject(s)

COVID-19; Psoriasis; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Psoriasis/diagnosis; Psoriasis/drug therapy; SARS-CoV-2; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15368

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google